A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP)
| Autor: | Moore, Raeanne C, Chattillion, Elizabeth A, Ceglowski, Jennifer, Ho, Jennifer, von Känel, Roland, Mills, Paul J, Ziegler, Michael G, Patterson, Thomas L, Grant, Igor, Mausbach, Brent T |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Interleukin-6 Depression education Business and Management Social Support Intervention Middle Aged Alzheimer's disease Cardiovascular disease Fibrin Fibrinogen Degradation Products Treatment Affect Clinical Psychology Caregivers Cardiovascular Diseases Behavior Therapy Humans Psychology Dementia Female Cognitive Sciences Biomarkers Aged |
| Zdroj: | Behaviour research and therapy, vol 51, iss 10 Moore, Raeanne C; Chattillion, Elizabeth A; Ceglowski, Jennifer; Ho, Jennifer; von Känel, Roland; Mills, Paul J; et al.(2013). A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP).. Behaviour research and therapy, 51(10), 623-632. doi: 10.1016/j.brat.2013.07.005. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/5hv4h4kt |
| DOI: | 10.1016/j.brat.2013.07.005. |
| Popis: | Dementia caregiving is associated with elevations in depressive symptoms and increased risk for cardiovascular diseases (CVD). This study evaluated the efficacy of the Pleasant Events Program (PEP), a 6-week Behavioral Activation intervention designed to reduce CVD risk and depressive symptoms in caregivers. One hundred dementia family caregivers were randomized to either the 6-week PEP intervention (N = 49) or a time-equivalent Information-Support (IS) control condition (N = 51). Assessments were completed pre- and post-intervention and at 1-year follow-up. Biological assessments included CVD risk markers Interleukin-6 (IL-6) and D-dimer. Psychosocial outcomes included depressive symptoms, positive affect, and negative affect. Participants receiving the PEP intervention had significantly greater reductions in IL-6 (p = .040), depressive symptoms (p = .039), and negative affect (p = .021) from pre- to post-treatment. For IL-6, clinically significant improvement was observed in 20.0% of PEP participants and 6.5% of IS participants. For depressive symptoms, clinically significant improvement was found for 32.7% of PEP vs 11.8% of IS participants. Group differences in change from baseline to 1-year follow-up were non-significant for all outcomes. The PEP program decreased depression and improved a measure of physiological health in older dementia caregivers. Future research should examine the efficacy of PEP for improving other CVD biomarkers and seek to sustain the intervention's effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|